Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c.

CKD SLC34A1 SLC34A3 kidney stones nephrocalcinosis osteomalacia osteoporosis outcome phosphate rickets

Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 20 02 2024
revised: 15 08 2024
accepted: 30 08 2024
medline: 27 10 2024
pubmed: 27 10 2024
entrez: 26 10 2024
Statut: aheadofprint

Résumé

Pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter 2a and 2c are rare causes of phosphate wasting. Since data on presentation and outcomes are scarce, we collected clinical, biochemical and genetic data via an online questionnaire and the support of European professional organizations. One hundred thirteen patients (86% children) from 90 families and 17 countries with pathogenic or likely pathogenic variants in SLC34A1 or SLC34A3 and a median follow-up of three years were analyzed. Biallelic SLC34A1 variant carriers showed polyuria, failure to thrive, vomiting, constipation, hypercalcemia and nephrocalcinosis in infancy, while biallelic SLC34A3 carriers presented in childhood or even adulthood with rickets/osteomalacia and/or osteopenia/osteoporosis, hypophosphatemia and, less frequently, nephrocalcinosis, while the prevalences of kidney stones were comparable. Adult biallelic SLC34A3 carriers had a six-fold increase chronic kidney disease (CKD) prevalence compared to the general population. All biallelic variant carriers shared a common biochemical pattern including elevated 1,25(OH)

Identifiants

pubmed: 39461557
pii: S0085-2538(24)00727-0
doi: 10.1016/j.kint.2024.08.035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Max Brunkhorst (M)

Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany.

Lena Brunkhorst (L)

Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany.

Helge Martens (H)

Department of Human Genetics, Hannover Medical School, Hannover, Germany.

Svetlana Papizh (S)

Veltishev Research and Clinical Institute for Pediatrics and Children Surgery of Pirogov Russian National Research Medical University, Moscow, Russia.

Martine Besouw (M)

Department of Pediatric Nephrology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Corinna Grasemann (C)

Department of Pediatrics, Ruhr-University Bochum, Bochum, Germany.

Serap Turan (S)

Department of Pediatric Endocrinology, Marmara University School of Medicine, Istanbul, Turkey.

Przemyslaw Sikora (P)

Department or Pediatric Nephrology, Medical University of Lublin, Lublin, Poland.

Milan Chromek (M)

Division of Pediatrics, CLINTEC, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Elisabeth Cornelissen (E)

Department of Pediatrics, Amalia Children´s Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.

Marc Fila (M)

Pediatric Nephrology Department, Hôpital Arnaud de Villeneuve, CHU of Montpellier, Montpellier, France.

Marc Lilien (M)

Department of Pediatric Nephrology, Wilhelmina Children´s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.

Jeremy Allgrove (J)

Great Ormond Street Hospital, London, United Kingdom.

Thomas J Neuhaus (TJ)

Children's Hospital Lucerne, Lucerne, Switzerland.

Mehmet Eltan (M)

Department of Pediatric Endocrinology, Marmara University School of Medicine, Istanbul, Turkey.

Laura Espinosa (L)

Hospital Universitario La Paz, Madrid, Spain.

Dirk Schnabel (D)

Center for Chronically Sick Children, Pediatric Endocrinology, University Medicine, Charitè Berlin, Germany.

Ibrahim Gokce (I)

Department of Pediatric Nephrology, Marmara University School of Medicine, Istanbul, Turkey.

Juan David González-Rodríguez (JD)

Department of Pediatric Nephrology, Santa Lucia University Hospital, Cartagena, Spain.

Priyanka Khandelwal (P)

All India Institute of Medical Sciences, New Delhi, India.

Mandy G Keijzer-Veen (MG)

Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.

Felix Lechner (F)

Children's Hospital Memmingen, Memmingen, Germany.

Maria Szczepańska (M)

Department of Pediatrics, Faculty of Medical Sciences in Zabrze, SUM in Katowice, Poland.

Marcin Zaniew (M)

Department of Pediatrics, University of Zielona Góra, Zielona Góra, Poland.

Justine Bacchetta (J)

Hospices Civils de Lyon, INSERM1033 Research Unit, Lyon, France.

Francesco Emma (F)

Division of Nephrology, Bambino Gesù Children´s Hospital, IRCCS, Rome, Italy.

Dieter Haffner (D)

Department of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany. Electronic address: haffner.dieter@mh-hannover.de.

Classifications MeSH